Robert E. Abernathy's Insider Trades & SAST Disclosures
Robert E. Abernathy's most recent trade in Avient Corp was a trade of 1,055 Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert E. Abernathy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,055 | 36,181 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 955 | 35,126 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 775 | 34,171 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 22,288 (0%) | 0% | - | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 806 | 33,396 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 808 | 32,590 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Abernathy Robert E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 834 | 31,782 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 984 | 30,948 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 20,081 (0%) | 0% | - | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 863 | 29,964 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 857 | 29,101 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 1,040 | 28,244 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 1,139 | 27,204 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 17,855 (0%) | 0% | - | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 880 | 26,065 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 717 | 25,185 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 744 | 23,841 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 15,125 (0%) | 0% | - | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 669 | 23,097 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 682 | 22,428 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,202 | 20,942 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Robert E. Abernathy | Director | Purchase of securities on an exchange or from another person at price $ 80.93 per share. | 11 Aug 2020 | 4,000 | 12,048 (0%) | 0% | 80.9 | 323,720 | Common Stock |
| Haemonetics Corp. | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 1,983 | 8,048 (0%) | 0% | - | Common Stock | |
| Avient Corp | Robert E. Abernathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 1,250 | 19,740 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges